- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02201121
Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure Variation
July 24, 2014 updated by: Ran Kong, Chinese PLA General Hospital
Although induced hypertension decreased SVV and PPV,the influences of stroke volume variation and pulse pressure variation caused by phenylephrine,dopamine and ephedrine were unknown.
Study Overview
Status
Completed
Conditions
Detailed Description
Pulse pressure variation (PPV) and stroke volume variation (SVV) during mechanical ventilation have been shown to be effective parameters to predict preload responsiveness.
Although induced hypertension decreases PPV and SVV, the influences of phenylephrine, dopamine and ephedrine on PPV and SVV are unknown.
Study Type
Interventional
Enrollment (Actual)
94
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 58 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Their American Society of Anesthesiologists (ASA) physical status was 1 or 2
- Body mass index (BMI) ranged from 18 to 26
- None of the patients had known diabetes mellitus, hypertension, cardiovascular, pulmonary, endocrinological, neurological diseases, or diseases that influenced intravascular fluid volume or balance
- All patients had a preoperative fast for at least 8 h and routine atropine intramuscular injection
Exclusion Criteria:
- Persistent arrhythmias
- Intraoperative application of vasoactive drugs except phenylephrine, dopamine and ephedrine
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: phenylephrine group, dopamine group, ephedrine group
phenylephrine group: use the phenylephrine to increase the SAP from low to high level. dopamine group: use the dopamine to increase the SAP from low to high level. ephedrine group:use the ephedrine to increase the SAP from low to high level. |
This research mainly study the effect of clinical commonly used vasoconstrictor drugs on blood pressure of pressure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
invasive arterial blood pressure as a Measure of Safety
Time Frame: DAY 1
|
if instability of circulation, stop the clinical trial
|
DAY 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
June 1, 2014
Study Registration Dates
First Submitted
July 22, 2014
First Submitted That Met QC Criteria
July 24, 2014
First Posted (Estimate)
July 25, 2014
Study Record Updates
Last Update Posted (Estimate)
July 25, 2014
Last Update Submitted That Met QC Criteria
July 24, 2014
Last Verified
October 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Protective Agents
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Cardiotonic Agents
- Dopamine Agents
- Respiratory System Agents
- Central Nervous System Stimulants
- Sympathomimetics
- Vasoconstrictor Agents
- Mydriatics
- Nasal Decongestants
- Adrenergic alpha-1 Receptor Agonists
- Ephedrine
- Dopamine
- Phenylephrine
- Oxymetazoline
Other Study ID Numbers
- plaghran001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circulation
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedCerebrovascular CirculationNetherlands
-
Medical University of ViennaCompleted
-
Technical University of MunichLudwig-Maximilians - University of Munich; German Heart CenterCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityNot yet recruiting
-
Sahlgrenska University Hospital, SwedenCompletedRenal Function Disorder | Complication of Extracorporeal Circulation | Kidney Circulation DisorderSweden
-
BayerCompletedCerebrovascular CirculationUnited Kingdom
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Completed
-
University of Wisconsin, MadisonNational Institutes of Health (NIH)Completed
-
Palacky UniversityČeské Budějovice HospitalUnknownCerebrovascular CirculationCzechia
-
St. Boniface HospitalNot yet recruiting
Clinical Trials on Influences of phenylephrine, dopamine and ephedrine on stroke volume variation and pulse pressure variation
-
Universitätsklinikum Hamburg-EppendorfUniversity of Kiel; University of Valencia; University of Witten/Herdecke; Szeged... and other collaboratorsCompletedReduction of Length of Hospitality Stay, Reduction of Perioperative ComplicationsGermany
-
Yonsei UniversityCompletedBowel ResectionKorea, Republic of
-
Humanitas Clinical and Research CenterSocietà Italiana Anestesia, Analgesia, Rianimazione e Terapia Intensiva -...RecruitingBlood Pressure | Complication,Postoperative | Intraoperative HypotensionItaly
-
Stephen H. Landy, M.D.GlaxoSmithKlineCompletedMigraineUnited States
-
University of NottinghamUnknownHealthy VolunteersUnited Kingdom
-
JongHae KimCompletedHypovolemia | Central Venous Catheter | Donor HepatectomyKorea, Republic of
-
Mylan Inc.DPT Laboratories, Ltd.CompletedAtopic DermatitisUnited States, Dominican Republic, Honduras
-
Geron CorporationCompletedMultiple MyelomaUnited States